MPC2 and Hypertension: Our findings suggest that GCN5L1-MPC2 signalling alters metabolic patterns during Ang II-induced CF differentiation and that blocking MCT1 disrupts the fibroblast-to-cardiomyocyte lactate shuttle and may attenuate cardiac remodelling in hypertension.